Publications by authors named "Vanessa Gazquez Garcia"
A real-life ImmunoCAT study: impact of molecular diagnosis through ImmunoCAP ISAC 112 on immunotherapy prescription in pollen-polysensitized patients in Catalonia, Spain.
Teresa Garriga-Baraut Moises Labrador-Horrillo Mercé Tena Concepción De Linares Olga Esteso-Hontoria Vanessa Gázquez-Garcia
Allergol Immunopathol (Madr)
July 2024
Article Synopsis
- Molecular diagnosis in allergology, particularly using the ImmunoCAP ISAC 112 microarray, improves identification of specific allergens in patients, enhancing the understanding of their allergies.
- A study conducted in Catalonia assessed this method's impact on diagnosis and treatment (specifically immunotherapy) in young patients with allergic conditions, showing significant shifts in treatment plans.
- Results indicated that over half of the patients (51%) had changes in their immunotherapy prescriptions based on molecular diagnostic findings, suggesting this approach leads to better-targeted treatments.
Background: Oral immunotherapy is a frequent treatment for the management of food allergies, but adverse events (AE) are common. This study assessed the outcome of cow's milk oral immunotherapy (MOIT) in severe cow`s milk-allergic patients treated with omalizumab in a real-life setting.
Methods: OmaBASE was a national, multicenter, open, and observational registry that collected clinical, immunologic, and treatment from patients with food allergy receiving omalizumab.